Physician profile
Daniel J Lecavalier
NPI 1326603473
$8,226.91
in general payments reported to CMS, 2019-2025
19 companies · $3,428 in 2025
The $3,428 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $101 · 2021: $1,427 · 2022: $312 · 2023: $1,420 · 2024: $1,389 · 2025: $3,428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,938 · Food and Beverage: $2,299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,938.16 |
| Food and Beverage | $2,298.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $3,297.94 | 2023-2025 | 7d Surgical System, Admiral, Northstar |
| Goode Surgical INC | $1,541.31 | 2019-2025 | |
| Synthes Gmbh | $836.47 | 2024 | |
| Centinel Spine, LLC | $799.96 | 2023 | Prodisc L |
| Stryker Corporation | $478.32 | 2021-2025 | Gamma, Pangea |
| Integra Lifesciences Corporation | $290.69 | 2023-2024 | Integra, Tenoglide, Integra Dermal Regeneration Template |
| Medtronic, INC. | $264.41 | 2023-2025 | Infinity Occipitocervical Upper Thoracic System, Mazor X System, Midas Rex |
| Zimvie INC. | $251.17 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $121.81 | 2023 | Iovera |
| Novo Nordisk INC | $89.01 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $88.32 | 2019 | |
| Acera Surgical, INC. | $41.74 | 2021-2025 | Restrata Wound Matrix |
| Baxter Healthcare | $22.92 | 2025 | Floseal |
| Si-Bone, INC. | $21.35 | 2022 | |
| Smith+Nephew, INC. | $19.48 | 2025 | Trigen Intertan |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $18.61 | 2025 | Stratafix, Surgiflo Hemostatic Matrix |
| Arthrex, INC. | $16.67 | 2023 | Arthrex |
| Cerapedics INC. | $14.78 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Lifenet Health | $11.95 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Lecavalier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.